Ovid Therapeutics
Price & Volume
Stats
See moreOpen | $1.04 |
Previous Close | $1.06 |
Day Range | $1.02-$1.06 |
52W Range | $0.68-$4.10 |
Market Cap | $73.8M |
Shares Short | 679,890 |
Financials
See moreRevenue (12 Mos) | $631,695 |
Revenue Growth (YoY) | 58.7% |
Gross Profit (12 Mos) | $1.5M |
Diluted EPS | -$0.46 |
News
See moreYahoo Finance • last year
Ovid Therapeutics Reports Third Quarter 2023 Financial Results and Corporate Updates
Yahoo Finance • last year
Ovid Therapeutics and Ligand Pharmaceuticals Enter into a $30 Million Agreement for a 13% Interest in Soticlestat Royalties and Milestones Extending Ovid’s Cash Runway into 2026
Yahoo Finance • last year
Ovid Therapeutics to Present at the Jefferies Biotech CNS/Neuro Summit
Yahoo Finance • last year
Ovid Therapeutics to Host Investor Event - R&D Day on Monday, October 2, 2023
About
CEO | Dr. Jeremy Max Levin Ba Zoology, Dphil, M.D., Mb Bchir, Ph.D. |
Address | 41 Ninth Avenue, New York, NY, United States, 10001 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 25 |
